EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature

YANG YANG; BIAO ZHANG; RUTIAN LI; BAORUI LIU; LIFENG WANG

doi:10.3892/ol.2016.4409

EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature

Oncology Letters ◽

10.3892/ol.2016.4409 ◽

2016 ◽

Vol 11 (5) ◽

pp. 3546-3550 ◽

Cited By ~ 10

Author(s):

YANG YANG ◽

BIAO ZHANG ◽

RUTIAN LI ◽

BAORUI LIU ◽

LIFENG WANG

Keyword(s):

Lung Cancer ◽

Case Report ◽

Kinase Inhibitor ◽

Small Cell ◽

Egfr Mutations ◽

Review Of The Literature ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Inhibitor Treatment ◽

Exon 19

Download Full-text

Comparison of the characteristics of uncommon epidermal growth factor receptor (EGFR) mutations and EGFR‑tyrosine kinase inhibitor treatment in patients with non‑small cell lung cancer from different ethnic groups

Experimental and Therapeutic Medicine ◽

10.3892/etm.2020.8612 ◽

2020 ◽

Author(s):

Qiao Zhang ◽

Yanyan Cui ◽

Jian Zhang ◽

Jiayideng Kenjiabieke ◽

Patiguli Aerxiding

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations

Investigational New Drugs ◽

10.1007/s10637-019-00732-4 ◽

2019 ◽

Vol 37 (6) ◽

pp. 1207-1217

Author(s):

Makoto Nishio ◽

Haruyasu Murakami ◽

Yuichiro Ohe ◽

Toyoaki Hida ◽

Hiroshi Sakai ◽

...

Keyword(s):

Lung Cancer ◽

Phase I Study ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Third Generation ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

CLINICAL ANALYSIS OF AFATINIB IN EGFR-TYROSINE KINASE INHIBITOR NAÏVE PATIENTS WITH NON-SMALL CELL LUNG CANCER HABORING EGFR MUTATIONS

Respirology ◽

10.1111/resp.13207_77 ◽

2017 ◽

Vol 22 ◽

pp. 114-114 ◽

Cited By ~ 1

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Clinical Analysis ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor

Download Full-text

Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyz023 ◽

2019 ◽

Vol 49 (6) ◽

pp. 554-558 ◽

Cited By ~ 5

Author(s):

Kazuhiro Usui ◽

Takuma Yokoyama ◽

Go Naka ◽

Hiroo Ishida ◽

Kazuma Kishi ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Egfr Mutant ◽

Inhibitor Treatment

Download Full-text

RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation

Lung Cancer ◽

10.1016/j.lungcan.2015.09.025 ◽

2015 ◽

Vol 90 (3) ◽

pp. 477-483 ◽

Cited By ~ 25

Author(s):

Tatsuya Yoshida ◽

Kiyotaka Yoh ◽

Seiji Niho ◽

Shigeki Umemura ◽

Shingo Matsumoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text

Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients

OncoTargets and Therapy ◽

10.2147/ott.s143569 ◽

2017 ◽

Vol Volume 10 ◽

pp. 4261-4267 ◽

Cited By ~ 1

Author(s):

Ling Peng ◽

Yina Wang ◽

Yemin Tang ◽

Lei Zeng ◽

Junfang Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text

Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment

BMC Pulmonary Medicine ◽

10.1186/s12890-016-0268-3 ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 13

Author(s):

Takehiro Izumo ◽

Yuji Matsumoto ◽

Christine Chavez ◽

Takaaki Tsuchida

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Small Cell ◽

Endobronchial Ultrasound ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Inhibitor Treatment

Download Full-text

EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China

Lung Cancer ◽

10.1016/j.lungcan.2016.01.018 ◽

2016 ◽

Vol 96 ◽

pp. 87-92 ◽

Cited By ~ 27

Author(s):

Jianlin Xu ◽

Bo Jin ◽

Tianqing Chu ◽

Xue Dong ◽

Haitang Yang ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Real World ◽

Kinase Inhibitor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor

Download Full-text

A meta-analysis of the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e20604 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e20604-e20604

Author(s):

Hongmei Xu ◽

Kaitlyn Minchella ◽

Diansong Zhou ◽

Nidal Al-Huniti

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Three Cases of Non-Small Cell Lung Cancer, Which Simultaneously Expressed Activating Epidermal Growth Factor Receptor (EGFR) Mutations and EGFR-Tyrosine Kinase Inhibitor (TKI) Resistance Mutations (T790M) Before Gefitinib Therapy

Haigan ◽

10.2482/haigan.53.52 ◽

2013 ◽

Vol 53 (1) ◽

pp. 52-58

Author(s):

Toru Hiura ◽

Yoshiki Hayashi ◽

Tetsuya Abe ◽

Hiroshi Tanaka ◽

Katsuo Yoshiya ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Resistance Mutations ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Tki Resistance ◽

Epidermal Growth

Download Full-text